Latest Development and Expert Outlook of Management of Psoriatic Arthritis

Access Activity

Overview / Abstract:

Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal, disabling disease,
commonly associated with skin psoriasis, and estimated to affect up to 42% of the
approximately 7.5 million people in the United States with psoriasis. There remains an
ongoing challenge among clinicians to diagnose and treat patients, as well as to stay abreast
of optimal treatment strategies. In this educational program, the latest biologic treatment
recommendations are reviewed, as well as clinical trial results for novel emerging therapies.
Clinician-patient communication examples are shared on how to engage patients in their
management, along with best-practice, stepwise recommendations to achieve remission with
minimal or low disease activity with the use of appropriate assessment and screening tools to
improve overall outcomes in the PsA patient.

At the conclusion of this activity, participants should be better able to:
• Describe the etiology and socioeconomic and psychosocial burden of PsA and the importance of early detection and treatment
• Incorporate classification criteria into assessment of suspected
PsA cases
• Identify PsA-associated comorbidities, such as CVD, obesity, and IBD, as well as their implication on the choice of treatment options
• Increase clinician communication to minimize differences in the assessment of PsA disease severity and to improve understanding of patient satisfaction with current treatment options
• Apply an integrated approach to therapeutic intervention, incorporating patient-centric evidence and best practice recommendations for each treatment domain of PsA
• Describe the mechanisms and latest safety and efficacy evidence for approved and emerging biologic and nonbiologic DMARDs for the treatment of patients with PsA


Sep 29, 2019


Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME


Online, Webinar / Webcast / Video

Credits / Hours

1.5 AMA PRA Category 1 Credit(s)



Presenters / Authors / Faculty

M. Elaine Husni, MD, MPH
Vice Chair, Rheumatology
Director, Arthritis and Musculoskeletal Center
Cleveland Clinic
Assistant Professor
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, Ohio

Joseph F. Merola, MD, MMSc
Assistant Professor, Harvard Medical School
Director, Clinical Unit for Research Innovation and Trials (CUReIT)
Director, Center for Skin and Related Musculoskeletal Diseases
Associate Program Director, Harvard Combined Internal Medicine-Dermatology Residency Training Program
Brigham and Women’s Hospital
Boston, Massachusetts

Activity Specialities / Related Topics

Dermatology, Primary Care, Rheumatology / Arthritis

Sponsors / Supporters / Grant Providers

This activity is supported by an independent educational grant from Celgene.

This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.

Keywords / Search Terms

Annenberg Center for Health Sciences at Eisenhower PsA Arthritis Psoriasis Management of PsA Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.